NCT02466217View on ClinicalTrials.gov

Phenomics in Autoimmune and Inflammatory Diseases

CompletedOBSERVATIONAL
Enrollment

537

Participants

Timeline

Start Date

July 29, 2015

Primary Completion Date

July 14, 2022

Study Completion Date

July 18, 2022

Conditions
Healthy VolunteerRheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus/Antiphospholipid SyndromeFMFCryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic SyndromeVasculitisUveitisMyositisCrohn's DiseaseUlcerative RectocolitisType 1 DiabetesUnclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy
Interventions
OTHER

1: AID groups

Clinical and Biological investigations

OTHER

2: Control groups

Clinical and Biological investigations

Trial Locations (2)

75012

Rhumatologie - Hôpital Saint-Antoine, Paris

75013

CIC Paris-Est, Hôpital PITIE SALPETRIERE, Paris

All Listed Sponsors
collaborator

National Research Agency, France

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02466217 - Phenomics in Autoimmune and Inflammatory Diseases | Biotech Hunter | Biotech Hunter